/Investor DB

HealthX Ventures — 2026 Investments

6 investments dated 2026 · listed companies and verified rows first · show all

Anura Connectanuraconnect.comSep 2026SEC filingmedium confidence

Anura Connect is a consulting firm that places vetted Epic (healthcare software) consultants with health systems, and represents specialized consultants seeking transparent engagements.

Future of WorkHealthtechMadison, US

WILLIAM NEILL(Executive Officer, Director)RACHEL NEILL(Executive Officer, Director)

Board seatMark Bakken· per SEC Form D · $1.1M raise · filed Sep 2026

KeyCarekeycare.orginSeries A · Mar 2026 · $27M

KeyCare builds virtual care technology and telehealth solutions to extend health system capacity and improve access to healthcare.

Digital HealthEnterprise SoftwareHealthtechSaaSChicago, US

Lyle Berkowitz(Founder)inSulabh Agarwal(Executive Officer, Director)inCarrie Nelson, MDinMike Robbins(Executive Officer)inAndy JacksoninJennifer Timmin

Board seatMark Bakken· per SEC Form D

Co-investors2Flo Ventures8VCBold Capital PartnersCorewell Health VenturesLRVHealthMarram Ventures+1 more

Vinyl Healthvinylhealth.aiin𝕏Jun 2026

Vinyl is an AI-powered personal health assistant that helps patients, caregivers, and doctors understand and coordinate care through plain-language summaries and shared health records.

AI & Machine LearningDigital HealthHealthtechMarlton, US

Dr. Kaitlan Baston(Founder)

BoardDustin Hufford(Director)

Board seatMark Bakken· per SEC Form D

Cardamomcardamom.healthinJan 2026 · $20M

Cardamom is a healthcare consulting and technology firm that helps healthcare organizations improve patient access, engagement, and retention through Epic-first configuration, CRM integration, and AI-enhanced methods.

AI & Machine LearningDigital HealthHealthtechMadison, US

Vivek Swaminathan(Executive Officer, Director)in

Co-investorsValspring Capital

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Amulet PBCNovir

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.